ArticlePediatric cardiology2025
Cardiac Magnetic Resonance Imaging in Pediatric Heart Transplant Recipients: Correlation with Cardiopulmonary Exercise Testing.
Article in Pediatric cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiparametric cardiac magnetic resonance (CMR) is increasingly used for rejection and coronary artery vasculopathy (CAV) surveillance in pediatric heart transplant recipients (PHTR). There is limited data regarding how graft assessment by multiparametric CMR may reflect functional capacity in PHTR. To explore the relationship between multiparametric CMR and markers of exercise capacity in PHTR. PHTR who underwent CMR within 1 year of cardiopulmonary exercise testing (CPET) were retrospectively reviewed. Those with submaximal effort on CPET (respiratory exchange ratio < 1.10), depressed function (left ventricular ejection fraction (LVEF) < 50% and/or right ventricular ejection fraction (RVEF) < 45%), or significant clinical events (rejection, new or worsening CAV, cardiac hospitalizations) between CMR and CPET were excluded. CMR variables included biventricular volumes, ejection fraction, cardiac index (CI), myocardial T2, T1/extracellular volume fraction (ECV), and myocardial perfusion reserve index (MPRI). CPET variables were VO
Indexed as
Identifiers
41273424What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.